Metabolic Disease clinical trials at UCSF
3 in progress, 1 open to eligible people
Metabolic diseases affect how the body uses food for energy and growth. UCSF is studying KK8123 in adults with X-linked hypophosphatemia, where the body doesn't use phosphorus properly. UCSF is aiming to learn more about treating these metabolic conditions with new approaches.
First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
open to eligible people ages 18-65
A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.
San Francisco, California and other locations
Encaleret Compared to Standard of Care in Participants With ADH1
Sorry, in progress, not accepting new patients
The primary purpose of the study is to understand the effectiveness, safety, and tolerability of encaleret when compared to standard of care (SoC) treatment in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1).
Oakland, California and other locations
ADH1 and ADH2 Disease Monitoring Study (DMS)
Sorry, in progress, not accepting new patients
A global, multi-center, Disease Monitoring Study (DMS) in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1) or Autosomal Dominant Hypocalcemia Type 2 (ADH2) designed to characterize ADH1 and ADH2 disease presentation and progression through retrospective (past) and longitudinal prospective (over time into the future) data collection.
Oakland, California and other locations
Our lead scientists for Metabolic Disease research studies include Farzana Perwad, MD.
Last updated: